RYTM - Rhythm Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$140.20
DETAILS
HIGH:
$157.00
LOW:
$125.00
MEDIAN:
$143.00
CONSENSUS:
$140.20
UPSIDE:
59.61%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 189.8 | 130.1 | 77.4 | 23.6 | 3.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 19.5 | 13.4 | 9.3 | 2.1 | 0.6 | 0.7 | 0.8 | 0.4 | 0.2 | 0.1 | 0 | 0 | 0 | 0 |
| Gross Profit | 170.3 | 116.8 | 68.1 | 21.5 | 2.6 | (0.7) | (0.8) | (0.4) | (0.2) | (0.1) | 0 | 0 | 0 | 0 |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 167.3 | 238.0 | 135.0 | 108.6 | 104.1 | 90.5 | 109.5 | 50.3 | 22.9 | 19.6 | 7.1 | 5.3 | 18.0 | 15.7 |
| SG&A Expenses | 194.9 | 144.3 | 117.5 | 92.0 | 68.5 | 46.1 | 36.5 | 28.1 | 9.5 | 6.3 | 3.4 | 1.2 | 3.4 | 2.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | (0.7) | (0.8) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 362.3 | 382.3 | 252.5 | 200.7 | 172.6 | 135.9 | 145.2 | 78.4 | 32.4 | 25.9 | 10.6 | 6.5 | 21.4 | 18.1 |
| Operating Income | ||||||||||||||
| Operating Income | (192.0) | (265.5) | (184.4) | (179.2) | (170.1) | (136.6) | (146) | (78.4) | (32.4) | (25.9) | (10.6) | (6.5) | (21.4) | (18.1) |
| Interest Expense | 20.6 | 20.6 | 13.9 | 5.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 15.3 | 14.7 | 13.9 | 4.0 | 0.4 | 2.6 | 5.3 | 4.4 | 0.6 | 0.0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||||
| EBITDA | (174.1) | (238.1) | (168.5) | (174.2) | (68.5) | (135.9) | (145.2) | (78.0) | (32.2) | (25.8) | (10.1) | 0 | (21.4) | (18.1) |
| EBIT | (175.5) | (239.7) | (170.2) | (175.9) | (69.6) | (136.6) | (146) | (78.4) | (32.4) | (25.9) | (11.1) | (6.5) | (21.4) | (18.1) |
| Income Before Tax | (196.0) | (260.3) | (184.1) | (181.1) | (69.6) | (134.0) | (140.7) | (74.1) | (33.7) | (25.9) | (11.1) | (6.5) | (21.4) | (18.1) |
| Income Tax Expense | 0.5 | 0.3 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (196.5) | (260.6) | (184.7) | (181.1) | (69.6) | (130.7) | (134.6) | (74.1) | (33.7) | (25.9) | (11.1) | (6.5) | (21.4) | (18.1) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | -3.11 | -4.34 | -3.20 | -3.51 | -1.37 | -2.96 | -3.70 | -2.39 | -1.26 | -1.55 | -1.09 | -0.64 | -0.43 | -0.36 |
| EPS (Diluted) | -3.11 | -4.34 | -3.20 | -3.51 | -1.37 | -2.96 | -3.70 | -2.39 | -1.26 | -1.55 | -1.09 | -0.64 | -0.43 | -0.36 |
| Shares Outstanding | 65.0 | 61.0 | 57.7 | 52.1 | 49.6 | 44.1 | 36.4 | 31.0 | 26.7 | 16.7 | 10.2 | 10.2 | 50.3 | 50.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 54.3 | 89.1 | 60.1 | 127.7 | 59.2 | 100.9 | 62.3 | 49.5 | 34.2 | 6.5 |
| Short-Term Investments | 334.6 | 231.4 | 215.8 | 205.6 | 235.6 | 71.9 | 230.2 | 202.5 | 113.8 | 4.0 |
| Net Receivables | 26.1 | 18.5 | 14.9 | 6.2 | 1.0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 25.8 | 18.7 | 8.6 | 2.9 | 0.1 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 10.0 | 8.8 | 6.7 | 7.4 | 4.0 | 3.0 | 3.5 | 1.3 | 1.1 | 0.2 |
| Total Current Assets | 466.9 | 374.2 | 308.3 | 354.2 | 308.4 | 181.7 | 302.4 | 258.7 | 150.7 | 11.2 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 4.2 | 4.1 | 2.1 | 3.4 | 4.3 | 5.0 | 5.7 | 1.1 | 0.8 | 0.9 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 5.3 | 6.2 | 7.0 | 7.9 | 4.7 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.3 | 7.8 | 15.3 | 17.0 | 12.1 | 0.4 | 0.4 | 0.4 | 0.2 | 0.2 |
| Total Non-Current Assets | 14.3 | 18.1 | 24.5 | 28.2 | 21.1 | 5.4 | 6.1 | 1.5 | 1.1 | 1.2 |
| Total Assets | 481.2 | 392.3 | 332.7 | 382.5 | 329.5 | 187.1 | 308.5 | 260.2 | 151.7 | 12.3 |
| Current Liabilities | ||||||||||
| Account Payables | 13.9 | 12.3 | 4.9 | 4.8 | 5.7 | 4.9 | 10.4 | 7.6 | 2.4 | 1.9 |
| Short-Term Debt | 7.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0.2 | 1.3 | 1.3 | 1.4 | 7 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 61.4 | 43.6 | 5.4 | 2.4 | 0.8 | 0.2 | 0.4 | 0.1 | 0.1 | 0.2 |
| Total Current Liabilities | 105.9 | 115.5 | 55.2 | 39.8 | 43.4 | 18.0 | 24.4 | 13.6 | 6.7 | 4.7 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 235.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | (3.3) | 108.3 | 107.3 | 77.2 | 0 | 0 | 0 | 0.4 | 0.2 | 0.3 |
| Total Non-Current Liabilities | 236.2 | 112.2 | 107.8 | 78.4 | 1.9 | 2.6 | 3.1 | 0.4 | 0.2 | 0.3 |
| Total Liabilities | 342.1 | 227.7 | 163.0 | 118.2 | 45.4 | 20.5 | 27.5 | 14.0 | 6.9 | 5.0 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,351.9) | (1,155.3) | (894.7) | (710.1) | (528.9) | (459.3) | (325.3) | (184.6) | (110.3) | (76.5) |
| Accumulated Other Comprehensive Income | (0.8) | (0.0) | 0.1 | (0.1) | (0.0) | 0.0 | 0 | 0 | 0 | (0.1) |
| Total Stockholders' Equity | 139.1 | 164.5 | 169.8 | 264.3 | 284.2 | 166.5 | 281.0 | 246.3 | 144.8 | 7.3 |
| Total Liabilities & Equity | 481.2 | 392.3 | 332.7 | 382.5 | 329.5 | 187.1 | 308.5 | 260.2 | 151.7 | 12.3 |
| Debt Metrics | ||||||||||
| Total Debt | 246.5 | 3.9 | 1.3 | 1.9 | 2.6 | 3.1 | 3.6 | 0 | 0 | 0 |
| Net Debt | 192.2 | (85.2) | (58.8) | (125.7) | (56.7) | (97.8) | (58.7) | (49.5) | (34.2) | (6.5) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (196.5) | (260.6) | (184.7) | (181.1) | (69.6) | (134.0) | (140.7) | (74.1) | (33.7) | (25.9) |
| Depreciation & Amortization | 1.3 | 1.6 | 1.8 | 1.7 | 1.2 | 0.7 | 0.8 | 0.4 | 0.2 | 0.1 |
| Stock-Based Compensation | 66.8 | 39.7 | 32.6 | 19.8 | 20.8 | 17.5 | 11.9 | 6.4 | 2.3 | 1.2 |
| Change in Working Capital | (1.0) | 10.6 | 4.8 | (19.7) | 1.9 | (5.9) | 5.1 | 0.7 | (0.0) | 1.3 |
| Other Non-Cash Items | 13.7 | 94.9 | 9.4 | 5.9 | (0.2) | (0.2) | 0.2 | 4.5 | (0.1) | 0.0 |
| Operating Cash Flow | (115.7) | (113.9) | (136.2) | (173.4) | (146.0) | (122.0) | (122.8) | (62.1) | (29.5) | (23.2) |
| Investing Activities | ||||||||||
| Capital Expenditure | (1.0) | 0 | (0.0) | (4.3) | (5.4) | (0.2) | (3.4) | (0.7) | (0.1) | (1.1) |
| Acquisitions | 0 | 0 | 0 | 4 | 100 | 0 | 24.6 | 0 | 0 | 0 |
| Purchases of Investments | (348.7) | (268.3) | (354.9) | (251.9) | (525.0) | (86.9) | (295.8) | (248.6) | (126.9) | (15.2) |
| Sales/Maturities of Investments | 252.5 | 260.6 | 355.0 | 284.2 | 361.2 | 245.6 | 271.2 | 162.2 | 17.0 | 11.2 |
| Other Investing Activities | (40) | (40.5) | (5.7) | (4) | 7 | 0 | (24.6) | (86.4) | (109.9) | (4.1) |
| Investing Cash Flow | (137.2) | (48.2) | (5.7) | 28.0 | (62.2) | 158.5 | (28.0) | (87.1) | (110.0) | (5.1) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | (12.9) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | (4.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (19.9) | 12.9 | 25.5 | 82.7 | 4.8 | 2.0 | 2.1 | 1.8 | 0.7 | 0 |
| Financing Cash Flow | 218.0 | 191.2 | 74.4 | 213.8 | 166.5 | 2.0 | 163.5 | 164.7 | 167.2 | 0 |
| Cash Position | ||||||||||
| Net Change in Cash | (34.8) | 29.2 | (67.6) | 68.4 | (41.7) | 38.6 | 12.8 | 15.5 | 27.7 | (28.3) |
| Cash at Beginning | 89.6 | 60.4 | 128.0 | 59.6 | 101.3 | 62.7 | 49.9 | 34.5 | 6.5 | 34.9 |
| Cash at End | 54.8 | 89.6 | 60.4 | 128.0 | 59.6 | 101.3 | 62.7 | 49.9 | 34.2 | 6.5 |
| Free Cash Flow | (116.6) | (113.9) | (136.2) | (177.7) | (151.4) | (122.2) | (126.1) | (62.8) | (29.6) | (24.3) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 189.8 | 130.1 | 77.4 | 23.6 | 3.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 170.3 | 116.8 | 68.1 | 21.5 | 2.6 | (0.7) | (0.8) | (0.4) | (0.2) | (0.1) | 0 | 0 | 0 | 0 |
| Operating Income | (192.0) | (265.5) | (184.4) | (179.2) | (170.1) | (136.6) | (146) | (78.4) | (32.4) | (25.9) | (10.6) | (6.5) | (21.4) | (18.1) |
| Net Income | (196.5) | (260.6) | (184.7) | (181.1) | (69.6) | (130.7) | (134.6) | (74.1) | (33.7) | (25.9) | (11.1) | (6.5) | (21.4) | (18.1) |
| EPS (Diluted) | -3.11 | -4.34 | -3.20 | -3.51 | -1.37 | -2.96 | -3.70 | -2.39 | -1.26 | -1.55 | -1.09 | -0.64 | -0.43 | -0.36 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 54.3 | 89.1 | 60.1 | 127.7 | 59.2 | 100.9 | 62.3 | 49.5 | 34.2 | 6.5 | ||||
| Total Assets | 481.2 | 392.3 | 332.7 | 382.5 | 329.5 | 187.1 | 308.5 | 260.2 | 151.7 | 12.3 | ||||
| Total Debt | 246.5 | 3.9 | 1.3 | 1.9 | 2.6 | 3.1 | 3.6 | 0 | 0 | 0 | ||||
| Stockholders' Equity | 139.1 | 164.5 | 169.8 | 264.3 | 284.2 | 166.5 | 281.0 | 246.3 | 144.8 | 7.3 | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | (115.7) | (113.9) | (136.2) | (173.4) | (146.0) | (122.0) | (122.8) | (62.1) | (29.5) | (23.2) | ||||
| Capital Expenditure | (1.0) | 0 | (0.0) | (4.3) | (5.4) | (0.2) | (3.4) | (0.7) | (0.1) | (1.1) | ||||
| Free Cash Flow | (116.6) | (113.9) | (136.2) | (177.7) | (151.4) | (122.2) | (126.1) | (62.8) | (29.6) | (24.3) | ||||